Article Citation
Tan YW. Is dose modification or discontinuation of nilotinib necessary in nilotinib-induced hyperbilirubinemia? World J Meta-Anal 2021; 9(6): 488-495 [DOI: 10.13105/wjma.v9.i6.488]
Please LOGIN to submit a new comment.